Evercore
Israel Akinrinsola is a Director in Global Healthcare Investment Banking at Evercore since June 2018, following previous roles as Vice President and Associate in the same sector. Akinrinsola has extensive experience in managing transactions across large pharmaceuticals, biotech, specialty pharma, and pharma services, with a focus on both domestic and cross-border deals in Europe and the US. Notable transaction experience includes advising major firms like Novo Nordisk and Sanofi on significant acquisitions and collaborations. Earlier roles at Barclays Investment Bank and EY included equity research and transaction advisory services, along with a strong foundation in financial modeling and valuation analysis. Akinrinsola holds an MSc in Investment Management from Bayes Business School and is a qualified Chartered Accountant from the Institute of Chartered Accountants Scotland.
This person is not in any teams
This person is not in any offices
Evercore
19 followers
Evercore (NYSE: EVR) is a premier global independent investment banking advisory firm. Evercore is dedicated to helping its clients achieve superior results through trusted independent and innovative advice on matters of strategic significance to boards of directors, management teams and shareholders, including mergers and acquisitions, strategic shareholder advisory, restructurings, and capital structure.